IPSEN : Innovation for patient care

  • Home
  • Our Products
  • Disease Areas
  • Sponsorship
  • The Ipsen Fund
  • Library
  • Contact us

Innovation for patient care

Intended audience: General Public

Focus

About Ipsen Limited

Ipsen Limited is the UK subsidiary of Ipsen, a European pharmaceutical group with over 20 products on the market and a total worldwide staff of nearly 4,200.


Ipsen Limited's Endocrinology and Oncology Business Unit is responsible for a portfolio of products including Decapeptyl® (triptorelin), Increlex® (mecasermin), NutropinAq® (somatropin), Somatuline® (lanreotide) Autogel®, and Somatuline® (lanreotide) LA.


The Neurology Business Unit is responsible for Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex).

Zoom

Somatuline distribution arrangements

Movianto UK (formerly Healthcare Logistics) is the sole distributor for Somatuline® Autogel® and Somatuline® LA in Great Britain.

Movianto Ireland (formerly Castlereagh Pharmaceuticals) is the sole distributor for Somatuline® Autogel®, Somatuline® LA and NutropinAq® in Northern Ireland.

Order processing and distribution for Ipsen's other products remain unchanged.

For full contact details click here

Our Products

All our products

Search
Career Area